Global Milbexime Anthelmintic Market Growth 2026-2032
The global Milbexime Anthelmintic market size is predicted to grow from US$ 100 million in 2025 to US$ 150 million in 2032; it is expected to grow at a CAGR of 6.1% from 2026 to 2032.
Milbemycin is a broad-spectrum veterinary anthelmintic with milbemycin as its main active ingredient. It belongs to the macrolide class of antiparasitic drugs and is primarily used for the prevention and treatment of internal parasites in companion animals such as dogs and cats. This type of drug works by acting on the nerve and muscle cells of the parasite, interfering with nerve signal transmission, causing paralysis and ultimately death. It is effective against roundworms, hookworms, whipworms, and heartworm larvae. Milbemycin is stable in its efficacy and has a high safety profile, commonly used in routine deworming programs for pets, and is an important component of modern pet medical and preventative medication systems. The upstream supplier is the milbemycin raw material, with major suppliers including Livzon Pharmaceutical and Hisun Pharmaceutical. The price of milbemycin varies significantly depending on the milbemycin content; common strengths include 1.8 mg, 2.3 mg, 4.5 mg, 15 mg, and 27.5 mg.
Against the backdrop of the continued expansion of the global pet economy and the continuous improvement of veterinary medical standardization, parasite control is shifting from "occasional treatment" to "long-term, systematic prevention." In this transformation, deworming medications are no longer just single-function products, but rather a crucial foundational component of modern pet health management systems. As one of the core products in this system, milbemectin is gradually establishing its long-term market position in the companion animal deworming field, with its industrial value and market potential becoming increasingly prominent.
Mirbectin belongs to the macrolide class of antiparasitic drugs and is primarily used for the prevention and treatment of internal parasites in companion animals such as dogs and cats. With its broad spectrum of action, clear mechanism of action, and high safety profile, milbemectin is widely used in regular pet deworming programs. It not only effectively prevents and treats various common intestinal parasites but also plays a vital role in key application scenarios such as heartworm larval prevention, becoming one of the "basic drugs" in the pet deworming medication system.
From the demand side, the growth of milbemectin deworming medication is closely related to the increase in the global pet population, the upgrading of pet ownership concepts, and the popularization of veterinary medical care. As pets are increasingly regarded as family members, pet owners are paying significantly more attention to health management, and regular deworming has become a standardized pet-keeping practice. This trend is already highly prevalent in mature markets such as Europe, the United States, and Japan, and is accelerating its penetration in emerging markets such as China, Southeast Asia, and Latin America, providing a continuous and stable demand foundation for the milbemectin deworming medication market.
From a product structure perspective, milbemectin deworming medication often exists in single-ingredient or compound formulations, and is used in combination with other deworming ingredients to improve coverage and ease of use. This trend towards compound and solution-based development means that milbemectin is no longer just a single drug ingredient, but is integrated into a complete pet parasite prevention and control solution, effectively enhancing its market stickiness and application depth.
In terms of the competitive landscape, the milbemectin deworming medication market exhibits a characteristic of "coexistence of branded formulations and generic products." International veterinary drug companies hold an advantage in high-end and mature markets due to their brands, distribution channels, and long-term clinical application experience. Meanwhile, with the improvement of raw material supply systems and the maturity of formulation technologies, companies with compliance capabilities and cost advantages are gradually entering the market, driving product coverage across more price ranges and regional markets. This structure allows the milbemime anthelmintic market to maintain stable growth while also possessing a certain degree of competitive vitality.
From a supply chain perspective, milbemime anthelmintics are highly dependent on the quality and stable supply of upstream raw materials. The purity, impurity control, and batch consistency of raw materials directly affect the safety and efficacy of downstream formulations. As veterinary drug regulatory requirements continue to tighten in various countries, formulation companies are paying increasing attention to the compliance and traceability of raw material sources, which is objectively driving the milbemime anthelmintic supply chain towards a quality-oriented and long-term cooperation model.
Looking ahead, the development of the milbemime anthelmintic market will focus more on preventative use, compound formulations, and standardized application. As pet healthcare shifts from a "treatment-oriented" to a "prevention-oriented" approach, the frequency of deworming medication use and the population it covers are expected to continue to expand; combination formulations and convenient administration methods will further improve user compliance; and with the continuous improvement of regulations and clinical standards, the importance of safety and long-term use data will also continue to increase.
LP Information, Inc. (LPI) ' newest research report, the “Milbexime Anthelmintic Industry Forecast” looks at past sales and reviews total world Milbexime Anthelmintic sales in 2025, providing a comprehensive analysis by region and market sector of projected Milbexime Anthelmintic sales for 2026 through 2032. With Milbexime Anthelmintic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Milbexime Anthelmintic industry.
This Insight Report provides a comprehensive analysis of the global Milbexime Anthelmintic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Milbexime Anthelmintic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Milbexime Anthelmintic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Milbexime Anthelmintic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Milbexime Anthelmintic.
This report presents a comprehensive overview, market shares, and growth opportunities of Milbexime Anthelmintic market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Milbemycin is a broad-spectrum veterinary anthelmintic with milbemycin as its main active ingredient. It belongs to the macrolide class of antiparasitic drugs and is primarily used for the prevention and treatment of internal parasites in companion animals such as dogs and cats. This type of drug works by acting on the nerve and muscle cells of the parasite, interfering with nerve signal transmission, causing paralysis and ultimately death. It is effective against roundworms, hookworms, whipworms, and heartworm larvae. Milbemycin is stable in its efficacy and has a high safety profile, commonly used in routine deworming programs for pets, and is an important component of modern pet medical and preventative medication systems. The upstream supplier is the milbemycin raw material, with major suppliers including Livzon Pharmaceutical and Hisun Pharmaceutical. The price of milbemycin varies significantly depending on the milbemycin content; common strengths include 1.8 mg, 2.3 mg, 4.5 mg, 15 mg, and 27.5 mg.
Against the backdrop of the continued expansion of the global pet economy and the continuous improvement of veterinary medical standardization, parasite control is shifting from "occasional treatment" to "long-term, systematic prevention." In this transformation, deworming medications are no longer just single-function products, but rather a crucial foundational component of modern pet health management systems. As one of the core products in this system, milbemectin is gradually establishing its long-term market position in the companion animal deworming field, with its industrial value and market potential becoming increasingly prominent.
Mirbectin belongs to the macrolide class of antiparasitic drugs and is primarily used for the prevention and treatment of internal parasites in companion animals such as dogs and cats. With its broad spectrum of action, clear mechanism of action, and high safety profile, milbemectin is widely used in regular pet deworming programs. It not only effectively prevents and treats various common intestinal parasites but also plays a vital role in key application scenarios such as heartworm larval prevention, becoming one of the "basic drugs" in the pet deworming medication system.
From the demand side, the growth of milbemectin deworming medication is closely related to the increase in the global pet population, the upgrading of pet ownership concepts, and the popularization of veterinary medical care. As pets are increasingly regarded as family members, pet owners are paying significantly more attention to health management, and regular deworming has become a standardized pet-keeping practice. This trend is already highly prevalent in mature markets such as Europe, the United States, and Japan, and is accelerating its penetration in emerging markets such as China, Southeast Asia, and Latin America, providing a continuous and stable demand foundation for the milbemectin deworming medication market.
From a product structure perspective, milbemectin deworming medication often exists in single-ingredient or compound formulations, and is used in combination with other deworming ingredients to improve coverage and ease of use. This trend towards compound and solution-based development means that milbemectin is no longer just a single drug ingredient, but is integrated into a complete pet parasite prevention and control solution, effectively enhancing its market stickiness and application depth.
In terms of the competitive landscape, the milbemectin deworming medication market exhibits a characteristic of "coexistence of branded formulations and generic products." International veterinary drug companies hold an advantage in high-end and mature markets due to their brands, distribution channels, and long-term clinical application experience. Meanwhile, with the improvement of raw material supply systems and the maturity of formulation technologies, companies with compliance capabilities and cost advantages are gradually entering the market, driving product coverage across more price ranges and regional markets. This structure allows the milbemime anthelmintic market to maintain stable growth while also possessing a certain degree of competitive vitality.
From a supply chain perspective, milbemime anthelmintics are highly dependent on the quality and stable supply of upstream raw materials. The purity, impurity control, and batch consistency of raw materials directly affect the safety and efficacy of downstream formulations. As veterinary drug regulatory requirements continue to tighten in various countries, formulation companies are paying increasing attention to the compliance and traceability of raw material sources, which is objectively driving the milbemime anthelmintic supply chain towards a quality-oriented and long-term cooperation model.
Looking ahead, the development of the milbemime anthelmintic market will focus more on preventative use, compound formulations, and standardized application. As pet healthcare shifts from a "treatment-oriented" to a "prevention-oriented" approach, the frequency of deworming medication use and the population it covers are expected to continue to expand; combination formulations and convenient administration methods will further improve user compliance; and with the continuous improvement of regulations and clinical standards, the importance of safety and long-term use data will also continue to increase.
LP Information, Inc. (LPI) ' newest research report, the “Milbexime Anthelmintic Industry Forecast” looks at past sales and reviews total world Milbexime Anthelmintic sales in 2025, providing a comprehensive analysis by region and market sector of projected Milbexime Anthelmintic sales for 2026 through 2032. With Milbexime Anthelmintic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Milbexime Anthelmintic industry.
This Insight Report provides a comprehensive analysis of the global Milbexime Anthelmintic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Milbexime Anthelmintic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Milbexime Anthelmintic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Milbexime Anthelmintic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Milbexime Anthelmintic.
This report presents a comprehensive overview, market shares, and growth opportunities of Milbexime Anthelmintic market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Milbexime + Afrana
- Milbexime + Praziquantel
- Others
- Oral Tablets
- Oral Granules
- Regular Preventative Treatment
- Therapeutic Treatment
- Cat
- Dog
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Elanco Animal Health
- Boehringer Ingelheim Animal Health
- Merck Animal Health
- VIRBAC SA
- Krka
- Zhejiang Hisun Pharmaceutical Co., Ltd
- What is the 10-year outlook for the global Milbexime Anthelmintic market?
- What factors are driving Milbexime Anthelmintic market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Milbexime Anthelmintic market opportunities vary by end market size?
- How does Milbexime Anthelmintic break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Milbexime Anthelmintic Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Milbexime Anthelmintic by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Milbexime Anthelmintic by Country/Region, 2021, 2025 & 2032
2.2 Milbexime Anthelmintic Segment by Type
2.2.1 Milbexime + Afrana
2.2.2 Milbexime + Praziquantel
2.2.3 Others
2.2.4 Milbexime Anthelmintic Sales by Type
2.2.4.1 Global Milbexime Anthelmintic Sales Market Share by Type (2021-2026)
2.2.4.2 Global Milbexime Anthelmintic Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Milbexime Anthelmintic Sale Price by Type (2021-2026)
2.3 Milbexime Anthelmintic Segment by Form
2.3.1 Oral Tablets
2.3.2 Oral Granules
2.3.3 Milbexime Anthelmintic Sales by Form
2.3.3.1 Global Milbexime Anthelmintic Sales Market Share by Form (2021-2026)
2.3.3.2 Global Milbexime Anthelmintic Revenue and Market Share by Form (2021-2026)
2.3.3.3 Global Milbexime Anthelmintic Sale Price by Form (2021-2026)
2.4 Milbexime Anthelmintic Segment by Function
2.4.1 Regular Preventative Treatment
2.4.2 Therapeutic Treatment
2.4.3 Milbexime Anthelmintic Sales by Function
2.4.3.1 Global Milbexime Anthelmintic Sales Market Share by Function (2021-2026)
2.4.3.2 Global Milbexime Anthelmintic Revenue and Market Share by Function (2021-2026)
2.4.3.3 Global Milbexime Anthelmintic Sale Price by Function (2021-2026)
2.5 Milbexime Anthelmintic Segment by Application
2.5.1 Cat
2.5.2 Dog
2.5.3 Other
2.5.4 Milbexime Anthelmintic Sales by Application
2.5.4.1 Global Milbexime Anthelmintic Sale Market Share by Application (2021-2026)
2.5.4.2 Global Milbexime Anthelmintic Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Milbexime Anthelmintic Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Milbexime Anthelmintic Breakdown Data by Company
3.1.1 Global Milbexime Anthelmintic Annual Sales by Company (2021-2026)
3.1.2 Global Milbexime Anthelmintic Sales Market Share by Company (2021-2026)
3.2 Global Milbexime Anthelmintic Annual Revenue by Company (2021-2026)
3.2.1 Global Milbexime Anthelmintic Revenue by Company (2021-2026)
3.2.2 Global Milbexime Anthelmintic Revenue Market Share by Company (2021-2026)
3.3 Global Milbexime Anthelmintic Sale Price by Company
3.4 Key Manufacturers Milbexime Anthelmintic Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Milbexime Anthelmintic Product Location Distribution
3.4.2 Players Milbexime Anthelmintic Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MILBEXIME ANTHELMINTIC BY GEOGRAPHIC REGION
4.1 World Historic Milbexime Anthelmintic Market Size by Geographic Region (2021-2026)
4.1.1 Global Milbexime Anthelmintic Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Milbexime Anthelmintic Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Milbexime Anthelmintic Market Size by Country/Region (2021-2026)
4.2.1 Global Milbexime Anthelmintic Annual Sales by Country/Region (2021-2026)
4.2.2 Global Milbexime Anthelmintic Annual Revenue by Country/Region (2021-2026)
4.3 Americas Milbexime Anthelmintic Sales Growth
4.4 APAC Milbexime Anthelmintic Sales Growth
4.5 Europe Milbexime Anthelmintic Sales Growth
4.6 Middle East & Africa Milbexime Anthelmintic Sales Growth
5 AMERICAS
5.1 Americas Milbexime Anthelmintic Sales by Country
5.1.1 Americas Milbexime Anthelmintic Sales by Country (2021-2026)
5.1.2 Americas Milbexime Anthelmintic Revenue by Country (2021-2026)
5.2 Americas Milbexime Anthelmintic Sales by Type (2021-2026)
5.3 Americas Milbexime Anthelmintic Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Milbexime Anthelmintic Sales by Region
6.1.1 APAC Milbexime Anthelmintic Sales by Region (2021-2026)
6.1.2 APAC Milbexime Anthelmintic Revenue by Region (2021-2026)
6.2 APAC Milbexime Anthelmintic Sales by Type (2021-2026)
6.3 APAC Milbexime Anthelmintic Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Milbexime Anthelmintic by Country
7.1.1 Europe Milbexime Anthelmintic Sales by Country (2021-2026)
7.1.2 Europe Milbexime Anthelmintic Revenue by Country (2021-2026)
7.2 Europe Milbexime Anthelmintic Sales by Type (2021-2026)
7.3 Europe Milbexime Anthelmintic Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Milbexime Anthelmintic by Country
8.1.1 Middle East & Africa Milbexime Anthelmintic Sales by Country (2021-2026)
8.1.2 Middle East & Africa Milbexime Anthelmintic Revenue by Country (2021-2026)
8.2 Middle East & Africa Milbexime Anthelmintic Sales by Type (2021-2026)
8.3 Middle East & Africa Milbexime Anthelmintic Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Milbexime Anthelmintic
10.3 Manufacturing Process Analysis of Milbexime Anthelmintic
10.4 Industry Chain Structure of Milbexime Anthelmintic
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Milbexime Anthelmintic Distributors
11.3 Milbexime Anthelmintic Customer
12 WORLD FORECAST REVIEW FOR MILBEXIME ANTHELMINTIC BY GEOGRAPHIC REGION
12.1 Global Milbexime Anthelmintic Market Size Forecast by Region
12.1.1 Global Milbexime Anthelmintic Forecast by Region (2027-2032)
12.1.2 Global Milbexime Anthelmintic Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Milbexime Anthelmintic Forecast by Type (2027-2032)
12.7 Global Milbexime Anthelmintic Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Elanco Animal Health
13.1.1 Elanco Animal Health Company Information
13.1.2 Elanco Animal Health Milbexime Anthelmintic Product Portfolios and Specifications
13.1.3 Elanco Animal Health Milbexime Anthelmintic Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Elanco Animal Health Main Business Overview
13.1.5 Elanco Animal Health Latest Developments
13.2 Boehringer Ingelheim Animal Health
13.2.1 Boehringer Ingelheim Animal Health Company Information
13.2.2 Boehringer Ingelheim Animal Health Milbexime Anthelmintic Product Portfolios and Specifications
13.2.3 Boehringer Ingelheim Animal Health Milbexime Anthelmintic Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Boehringer Ingelheim Animal Health Main Business Overview
13.2.5 Boehringer Ingelheim Animal Health Latest Developments
13.3 Merck Animal Health
13.3.1 Merck Animal Health Company Information
13.3.2 Merck Animal Health Milbexime Anthelmintic Product Portfolios and Specifications
13.3.3 Merck Animal Health Milbexime Anthelmintic Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Merck Animal Health Main Business Overview
13.3.5 Merck Animal Health Latest Developments
13.4 VIRBAC SA
13.4.1 VIRBAC SA Company Information
13.4.2 VIRBAC SA Milbexime Anthelmintic Product Portfolios and Specifications
13.4.3 VIRBAC SA Milbexime Anthelmintic Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 VIRBAC SA Main Business Overview
13.4.5 VIRBAC SA Latest Developments
13.5 Krka
13.5.1 Krka Company Information
13.5.2 Krka Milbexime Anthelmintic Product Portfolios and Specifications
13.5.3 Krka Milbexime Anthelmintic Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Krka Main Business Overview
13.5.5 Krka Latest Developments
13.6 Zhejiang Hisun Pharmaceutical Co., Ltd
13.6.1 Zhejiang Hisun Pharmaceutical Co., Ltd Company Information
13.6.2 Zhejiang Hisun Pharmaceutical Co., Ltd Milbexime Anthelmintic Product Portfolios and Specifications
13.6.3 Zhejiang Hisun Pharmaceutical Co., Ltd Milbexime Anthelmintic Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Zhejiang Hisun Pharmaceutical Co., Ltd Main Business Overview
13.6.5 Zhejiang Hisun Pharmaceutical Co., Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Milbexime Anthelmintic Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Milbexime Anthelmintic by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Milbexime Anthelmintic by Country/Region, 2021, 2025 & 2032
2.2 Milbexime Anthelmintic Segment by Type
2.2.1 Milbexime + Afrana
2.2.2 Milbexime + Praziquantel
2.2.3 Others
2.2.4 Milbexime Anthelmintic Sales by Type
2.2.4.1 Global Milbexime Anthelmintic Sales Market Share by Type (2021-2026)
2.2.4.2 Global Milbexime Anthelmintic Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Milbexime Anthelmintic Sale Price by Type (2021-2026)
2.3 Milbexime Anthelmintic Segment by Form
2.3.1 Oral Tablets
2.3.2 Oral Granules
2.3.3 Milbexime Anthelmintic Sales by Form
2.3.3.1 Global Milbexime Anthelmintic Sales Market Share by Form (2021-2026)
2.3.3.2 Global Milbexime Anthelmintic Revenue and Market Share by Form (2021-2026)
2.3.3.3 Global Milbexime Anthelmintic Sale Price by Form (2021-2026)
2.4 Milbexime Anthelmintic Segment by Function
2.4.1 Regular Preventative Treatment
2.4.2 Therapeutic Treatment
2.4.3 Milbexime Anthelmintic Sales by Function
2.4.3.1 Global Milbexime Anthelmintic Sales Market Share by Function (2021-2026)
2.4.3.2 Global Milbexime Anthelmintic Revenue and Market Share by Function (2021-2026)
2.4.3.3 Global Milbexime Anthelmintic Sale Price by Function (2021-2026)
2.5 Milbexime Anthelmintic Segment by Application
2.5.1 Cat
2.5.2 Dog
2.5.3 Other
2.5.4 Milbexime Anthelmintic Sales by Application
2.5.4.1 Global Milbexime Anthelmintic Sale Market Share by Application (2021-2026)
2.5.4.2 Global Milbexime Anthelmintic Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Milbexime Anthelmintic Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Milbexime Anthelmintic Breakdown Data by Company
3.1.1 Global Milbexime Anthelmintic Annual Sales by Company (2021-2026)
3.1.2 Global Milbexime Anthelmintic Sales Market Share by Company (2021-2026)
3.2 Global Milbexime Anthelmintic Annual Revenue by Company (2021-2026)
3.2.1 Global Milbexime Anthelmintic Revenue by Company (2021-2026)
3.2.2 Global Milbexime Anthelmintic Revenue Market Share by Company (2021-2026)
3.3 Global Milbexime Anthelmintic Sale Price by Company
3.4 Key Manufacturers Milbexime Anthelmintic Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Milbexime Anthelmintic Product Location Distribution
3.4.2 Players Milbexime Anthelmintic Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MILBEXIME ANTHELMINTIC BY GEOGRAPHIC REGION
4.1 World Historic Milbexime Anthelmintic Market Size by Geographic Region (2021-2026)
4.1.1 Global Milbexime Anthelmintic Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Milbexime Anthelmintic Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Milbexime Anthelmintic Market Size by Country/Region (2021-2026)
4.2.1 Global Milbexime Anthelmintic Annual Sales by Country/Region (2021-2026)
4.2.2 Global Milbexime Anthelmintic Annual Revenue by Country/Region (2021-2026)
4.3 Americas Milbexime Anthelmintic Sales Growth
4.4 APAC Milbexime Anthelmintic Sales Growth
4.5 Europe Milbexime Anthelmintic Sales Growth
4.6 Middle East & Africa Milbexime Anthelmintic Sales Growth
5 AMERICAS
5.1 Americas Milbexime Anthelmintic Sales by Country
5.1.1 Americas Milbexime Anthelmintic Sales by Country (2021-2026)
5.1.2 Americas Milbexime Anthelmintic Revenue by Country (2021-2026)
5.2 Americas Milbexime Anthelmintic Sales by Type (2021-2026)
5.3 Americas Milbexime Anthelmintic Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Milbexime Anthelmintic Sales by Region
6.1.1 APAC Milbexime Anthelmintic Sales by Region (2021-2026)
6.1.2 APAC Milbexime Anthelmintic Revenue by Region (2021-2026)
6.2 APAC Milbexime Anthelmintic Sales by Type (2021-2026)
6.3 APAC Milbexime Anthelmintic Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Milbexime Anthelmintic by Country
7.1.1 Europe Milbexime Anthelmintic Sales by Country (2021-2026)
7.1.2 Europe Milbexime Anthelmintic Revenue by Country (2021-2026)
7.2 Europe Milbexime Anthelmintic Sales by Type (2021-2026)
7.3 Europe Milbexime Anthelmintic Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Milbexime Anthelmintic by Country
8.1.1 Middle East & Africa Milbexime Anthelmintic Sales by Country (2021-2026)
8.1.2 Middle East & Africa Milbexime Anthelmintic Revenue by Country (2021-2026)
8.2 Middle East & Africa Milbexime Anthelmintic Sales by Type (2021-2026)
8.3 Middle East & Africa Milbexime Anthelmintic Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Milbexime Anthelmintic
10.3 Manufacturing Process Analysis of Milbexime Anthelmintic
10.4 Industry Chain Structure of Milbexime Anthelmintic
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Milbexime Anthelmintic Distributors
11.3 Milbexime Anthelmintic Customer
12 WORLD FORECAST REVIEW FOR MILBEXIME ANTHELMINTIC BY GEOGRAPHIC REGION
12.1 Global Milbexime Anthelmintic Market Size Forecast by Region
12.1.1 Global Milbexime Anthelmintic Forecast by Region (2027-2032)
12.1.2 Global Milbexime Anthelmintic Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Milbexime Anthelmintic Forecast by Type (2027-2032)
12.7 Global Milbexime Anthelmintic Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Elanco Animal Health
13.1.1 Elanco Animal Health Company Information
13.1.2 Elanco Animal Health Milbexime Anthelmintic Product Portfolios and Specifications
13.1.3 Elanco Animal Health Milbexime Anthelmintic Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Elanco Animal Health Main Business Overview
13.1.5 Elanco Animal Health Latest Developments
13.2 Boehringer Ingelheim Animal Health
13.2.1 Boehringer Ingelheim Animal Health Company Information
13.2.2 Boehringer Ingelheim Animal Health Milbexime Anthelmintic Product Portfolios and Specifications
13.2.3 Boehringer Ingelheim Animal Health Milbexime Anthelmintic Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Boehringer Ingelheim Animal Health Main Business Overview
13.2.5 Boehringer Ingelheim Animal Health Latest Developments
13.3 Merck Animal Health
13.3.1 Merck Animal Health Company Information
13.3.2 Merck Animal Health Milbexime Anthelmintic Product Portfolios and Specifications
13.3.3 Merck Animal Health Milbexime Anthelmintic Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Merck Animal Health Main Business Overview
13.3.5 Merck Animal Health Latest Developments
13.4 VIRBAC SA
13.4.1 VIRBAC SA Company Information
13.4.2 VIRBAC SA Milbexime Anthelmintic Product Portfolios and Specifications
13.4.3 VIRBAC SA Milbexime Anthelmintic Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 VIRBAC SA Main Business Overview
13.4.5 VIRBAC SA Latest Developments
13.5 Krka
13.5.1 Krka Company Information
13.5.2 Krka Milbexime Anthelmintic Product Portfolios and Specifications
13.5.3 Krka Milbexime Anthelmintic Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Krka Main Business Overview
13.5.5 Krka Latest Developments
13.6 Zhejiang Hisun Pharmaceutical Co., Ltd
13.6.1 Zhejiang Hisun Pharmaceutical Co., Ltd Company Information
13.6.2 Zhejiang Hisun Pharmaceutical Co., Ltd Milbexime Anthelmintic Product Portfolios and Specifications
13.6.3 Zhejiang Hisun Pharmaceutical Co., Ltd Milbexime Anthelmintic Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Zhejiang Hisun Pharmaceutical Co., Ltd Main Business Overview
13.6.5 Zhejiang Hisun Pharmaceutical Co., Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Milbexime Anthelmintic Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Milbexime Anthelmintic Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Milbexime + Afrana
Table 4. Major Players of Milbexime + Praziquantel
Table 5. Major Players of Others
Table 6. Global Milbexime Anthelmintic Sales by Type (2021-2026) & (K Units)
Table 7. Global Milbexime Anthelmintic Sales Market Share by Type (2021-2026)
Table 8. Global Milbexime Anthelmintic Revenue by Type (2021-2026) & ($ million)
Table 9. Global Milbexime Anthelmintic Revenue Market Share by Type (2021-2026)
Table 10. Global Milbexime Anthelmintic Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Oral Tablets
Table 12. Major Players of Oral Granules
Table 13. Global Milbexime Anthelmintic Sales by Form (2021-2026) & (K Units)
Table 14. Global Milbexime Anthelmintic Sales Market Share by Form (2021-2026)
Table 15. Global Milbexime Anthelmintic Revenue by Form (2021-2026) & ($ million)
Table 16. Global Milbexime Anthelmintic Revenue Market Share by Form (2021-2026)
Table 17. Global Milbexime Anthelmintic Sale Price by Form (2021-2026) & (US$/Unit)
Table 18. Major Players of Regular Preventative Treatment
Table 19. Major Players of Therapeutic Treatment
Table 20. Global Milbexime Anthelmintic Sales by Function (2021-2026) & (K Units)
Table 21. Global Milbexime Anthelmintic Sales Market Share by Function (2021-2026)
Table 22. Global Milbexime Anthelmintic Revenue by Function (2021-2026) & ($ million)
Table 23. Global Milbexime Anthelmintic Revenue Market Share by Function (2021-2026)
Table 24. Global Milbexime Anthelmintic Sale Price by Function (2021-2026) & (US$/Unit)
Table 25. Global Milbexime Anthelmintic Sale by Application (2021-2026) & (K Units)
Table 26. Global Milbexime Anthelmintic Sale Market Share by Application (2021-2026)
Table 27. Global Milbexime Anthelmintic Revenue by Application (2021-2026) & ($ million)
Table 28. Global Milbexime Anthelmintic Revenue Market Share by Application (2021-2026)
Table 29. Global Milbexime Anthelmintic Sale Price by Application (2021-2026) & (US$/Unit)
Table 30. Global Milbexime Anthelmintic Sales by Company (2021-2026) & (K Units)
Table 31. Global Milbexime Anthelmintic Sales Market Share by Company (2021-2026)
Table 32. Global Milbexime Anthelmintic Revenue by Company (2021-2026) & ($ millions)
Table 33. Global Milbexime Anthelmintic Revenue Market Share by Company (2021-2026)
Table 34. Global Milbexime Anthelmintic Sale Price by Company (2021-2026) & (US$/Unit)
Table 35. Key Manufacturers Milbexime Anthelmintic Producing Area Distribution and Sales Area
Table 36. Players Milbexime Anthelmintic Products Offered
Table 37. Milbexime Anthelmintic Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Market M&A Activity & Strategy
Table 40. Global Milbexime Anthelmintic Sales by Geographic Region (2021-2026) & (K Units)
Table 41. Global Milbexime Anthelmintic Sales Market Share Geographic Region (2021-2026)
Table 42. Global Milbexime Anthelmintic Revenue by Geographic Region (2021-2026) & ($ millions)
Table 43. Global Milbexime Anthelmintic Revenue Market Share by Geographic Region (2021-2026)
Table 44. Global Milbexime Anthelmintic Sales by Country/Region (2021-2026) & (K Units)
Table 45. Global Milbexime Anthelmintic Sales Market Share by Country/Region (2021-2026)
Table 46. Global Milbexime Anthelmintic Revenue by Country/Region (2021-2026) & ($ millions)
Table 47. Global Milbexime Anthelmintic Revenue Market Share by Country/Region (2021-2026)
Table 48. Americas Milbexime Anthelmintic Sales by Country (2021-2026) & (K Units)
Table 49. Americas Milbexime Anthelmintic Sales Market Share by Country (2021-2026)
Table 50. Americas Milbexime Anthelmintic Revenue by Country (2021-2026) & ($ millions)
Table 51. Americas Milbexime Anthelmintic Sales by Type (2021-2026) & (K Units)
Table 52. Americas Milbexime Anthelmintic Sales by Application (2021-2026) & (K Units)
Table 53. APAC Milbexime Anthelmintic Sales by Region (2021-2026) & (K Units)
Table 54. APAC Milbexime Anthelmintic Sales Market Share by Region (2021-2026)
Table 55. APAC Milbexime Anthelmintic Revenue by Region (2021-2026) & ($ millions)
Table 56. APAC Milbexime Anthelmintic Sales by Type (2021-2026) & (K Units)
Table 57. APAC Milbexime Anthelmintic Sales by Application (2021-2026) & (K Units)
Table 58. Europe Milbexime Anthelmintic Sales by Country (2021-2026) & (K Units)
Table 59. Europe Milbexime Anthelmintic Revenue by Country (2021-2026) & ($ millions)
Table 60. Europe Milbexime Anthelmintic Sales by Type (2021-2026) & (K Units)
Table 61. Europe Milbexime Anthelmintic Sales by Application (2021-2026) & (K Units)
Table 62. Middle East & Africa Milbexime Anthelmintic Sales by Country (2021-2026) & (K Units)
Table 63. Middle East & Africa Milbexime Anthelmintic Revenue Market Share by Country (2021-2026)
Table 64. Middle East & Africa Milbexime Anthelmintic Sales by Type (2021-2026) & (K Units)
Table 65. Middle East & Africa Milbexime Anthelmintic Sales by Application (2021-2026) & (K Units)
Table 66. Key Market Drivers & Growth Opportunities of Milbexime Anthelmintic
Table 67. Key Market Challenges & Risks of Milbexime Anthelmintic
Table 68. Key Industry Trends of Milbexime Anthelmintic
Table 69. Milbexime Anthelmintic Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Milbexime Anthelmintic Distributors List
Table 72. Milbexime Anthelmintic Customer List
Table 73. Global Milbexime Anthelmintic Sales Forecast by Region (2027-2032) & (K Units)
Table 74. Global Milbexime Anthelmintic Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Americas Milbexime Anthelmintic Sales Forecast by Country (2027-2032) & (K Units)
Table 76. Americas Milbexime Anthelmintic Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. APAC Milbexime Anthelmintic Sales Forecast by Region (2027-2032) & (K Units)
Table 78. APAC Milbexime Anthelmintic Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Europe Milbexime Anthelmintic Sales Forecast by Country (2027-2032) & (K Units)
Table 80. Europe Milbexime Anthelmintic Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. Middle East & Africa Milbexime Anthelmintic Sales Forecast by Country (2027-2032) & (K Units)
Table 82. Middle East & Africa Milbexime Anthelmintic Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Global Milbexime Anthelmintic Sales Forecast by Type (2027-2032) & (K Units)
Table 84. Global Milbexime Anthelmintic Revenue Forecast by Type (2027-2032) & ($ millions)
Table 85. Global Milbexime Anthelmintic Sales Forecast by Application (2027-2032) & (K Units)
Table 86. Global Milbexime Anthelmintic Revenue Forecast by Application (2027-2032) & ($ millions)
Table 87. Elanco Animal Health Basic Information, Milbexime Anthelmintic Manufacturing Base, Sales Area and Its Competitors
Table 88. Elanco Animal Health Milbexime Anthelmintic Product Portfolios and Specifications
Table 89. Elanco Animal Health Milbexime Anthelmintic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Elanco Animal Health Main Business
Table 91. Elanco Animal Health Latest Developments
Table 92. Boehringer Ingelheim Animal Health Basic Information, Milbexime Anthelmintic Manufacturing Base, Sales Area and Its Competitors
Table 93. Boehringer Ingelheim Animal Health Milbexime Anthelmintic Product Portfolios and Specifications
Table 94. Boehringer Ingelheim Animal Health Milbexime Anthelmintic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Boehringer Ingelheim Animal Health Main Business
Table 96. Boehringer Ingelheim Animal Health Latest Developments
Table 97. Merck Animal Health Basic Information, Milbexime Anthelmintic Manufacturing Base, Sales Area and Its Competitors
Table 98. Merck Animal Health Milbexime Anthelmintic Product Portfolios and Specifications
Table 99. Merck Animal Health Milbexime Anthelmintic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Merck Animal Health Main Business
Table 101. Merck Animal Health Latest Developments
Table 102. VIRBAC SA Basic Information, Milbexime Anthelmintic Manufacturing Base, Sales Area and Its Competitors
Table 103. VIRBAC SA Milbexime Anthelmintic Product Portfolios and Specifications
Table 104. VIRBAC SA Milbexime Anthelmintic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. VIRBAC SA Main Business
Table 106. VIRBAC SA Latest Developments
Table 107. Krka Basic Information, Milbexime Anthelmintic Manufacturing Base, Sales Area and Its Competitors
Table 108. Krka Milbexime Anthelmintic Product Portfolios and Specifications
Table 109. Krka Milbexime Anthelmintic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Krka Main Business
Table 111. Krka Latest Developments
Table 112. Zhejiang Hisun Pharmaceutical Co., Ltd Basic Information, Milbexime Anthelmintic Manufacturing Base, Sales Area and Its Competitors
Table 113. Zhejiang Hisun Pharmaceutical Co., Ltd Milbexime Anthelmintic Product Portfolios and Specifications
Table 114. Zhejiang Hisun Pharmaceutical Co., Ltd Milbexime Anthelmintic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Zhejiang Hisun Pharmaceutical Co., Ltd Main Business
Table 116. Zhejiang Hisun Pharmaceutical Co., Ltd Latest Developments
Table 1. Milbexime Anthelmintic Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Milbexime Anthelmintic Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Milbexime + Afrana
Table 4. Major Players of Milbexime + Praziquantel
Table 5. Major Players of Others
Table 6. Global Milbexime Anthelmintic Sales by Type (2021-2026) & (K Units)
Table 7. Global Milbexime Anthelmintic Sales Market Share by Type (2021-2026)
Table 8. Global Milbexime Anthelmintic Revenue by Type (2021-2026) & ($ million)
Table 9. Global Milbexime Anthelmintic Revenue Market Share by Type (2021-2026)
Table 10. Global Milbexime Anthelmintic Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Oral Tablets
Table 12. Major Players of Oral Granules
Table 13. Global Milbexime Anthelmintic Sales by Form (2021-2026) & (K Units)
Table 14. Global Milbexime Anthelmintic Sales Market Share by Form (2021-2026)
Table 15. Global Milbexime Anthelmintic Revenue by Form (2021-2026) & ($ million)
Table 16. Global Milbexime Anthelmintic Revenue Market Share by Form (2021-2026)
Table 17. Global Milbexime Anthelmintic Sale Price by Form (2021-2026) & (US$/Unit)
Table 18. Major Players of Regular Preventative Treatment
Table 19. Major Players of Therapeutic Treatment
Table 20. Global Milbexime Anthelmintic Sales by Function (2021-2026) & (K Units)
Table 21. Global Milbexime Anthelmintic Sales Market Share by Function (2021-2026)
Table 22. Global Milbexime Anthelmintic Revenue by Function (2021-2026) & ($ million)
Table 23. Global Milbexime Anthelmintic Revenue Market Share by Function (2021-2026)
Table 24. Global Milbexime Anthelmintic Sale Price by Function (2021-2026) & (US$/Unit)
Table 25. Global Milbexime Anthelmintic Sale by Application (2021-2026) & (K Units)
Table 26. Global Milbexime Anthelmintic Sale Market Share by Application (2021-2026)
Table 27. Global Milbexime Anthelmintic Revenue by Application (2021-2026) & ($ million)
Table 28. Global Milbexime Anthelmintic Revenue Market Share by Application (2021-2026)
Table 29. Global Milbexime Anthelmintic Sale Price by Application (2021-2026) & (US$/Unit)
Table 30. Global Milbexime Anthelmintic Sales by Company (2021-2026) & (K Units)
Table 31. Global Milbexime Anthelmintic Sales Market Share by Company (2021-2026)
Table 32. Global Milbexime Anthelmintic Revenue by Company (2021-2026) & ($ millions)
Table 33. Global Milbexime Anthelmintic Revenue Market Share by Company (2021-2026)
Table 34. Global Milbexime Anthelmintic Sale Price by Company (2021-2026) & (US$/Unit)
Table 35. Key Manufacturers Milbexime Anthelmintic Producing Area Distribution and Sales Area
Table 36. Players Milbexime Anthelmintic Products Offered
Table 37. Milbexime Anthelmintic Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Market M&A Activity & Strategy
Table 40. Global Milbexime Anthelmintic Sales by Geographic Region (2021-2026) & (K Units)
Table 41. Global Milbexime Anthelmintic Sales Market Share Geographic Region (2021-2026)
Table 42. Global Milbexime Anthelmintic Revenue by Geographic Region (2021-2026) & ($ millions)
Table 43. Global Milbexime Anthelmintic Revenue Market Share by Geographic Region (2021-2026)
Table 44. Global Milbexime Anthelmintic Sales by Country/Region (2021-2026) & (K Units)
Table 45. Global Milbexime Anthelmintic Sales Market Share by Country/Region (2021-2026)
Table 46. Global Milbexime Anthelmintic Revenue by Country/Region (2021-2026) & ($ millions)
Table 47. Global Milbexime Anthelmintic Revenue Market Share by Country/Region (2021-2026)
Table 48. Americas Milbexime Anthelmintic Sales by Country (2021-2026) & (K Units)
Table 49. Americas Milbexime Anthelmintic Sales Market Share by Country (2021-2026)
Table 50. Americas Milbexime Anthelmintic Revenue by Country (2021-2026) & ($ millions)
Table 51. Americas Milbexime Anthelmintic Sales by Type (2021-2026) & (K Units)
Table 52. Americas Milbexime Anthelmintic Sales by Application (2021-2026) & (K Units)
Table 53. APAC Milbexime Anthelmintic Sales by Region (2021-2026) & (K Units)
Table 54. APAC Milbexime Anthelmintic Sales Market Share by Region (2021-2026)
Table 55. APAC Milbexime Anthelmintic Revenue by Region (2021-2026) & ($ millions)
Table 56. APAC Milbexime Anthelmintic Sales by Type (2021-2026) & (K Units)
Table 57. APAC Milbexime Anthelmintic Sales by Application (2021-2026) & (K Units)
Table 58. Europe Milbexime Anthelmintic Sales by Country (2021-2026) & (K Units)
Table 59. Europe Milbexime Anthelmintic Revenue by Country (2021-2026) & ($ millions)
Table 60. Europe Milbexime Anthelmintic Sales by Type (2021-2026) & (K Units)
Table 61. Europe Milbexime Anthelmintic Sales by Application (2021-2026) & (K Units)
Table 62. Middle East & Africa Milbexime Anthelmintic Sales by Country (2021-2026) & (K Units)
Table 63. Middle East & Africa Milbexime Anthelmintic Revenue Market Share by Country (2021-2026)
Table 64. Middle East & Africa Milbexime Anthelmintic Sales by Type (2021-2026) & (K Units)
Table 65. Middle East & Africa Milbexime Anthelmintic Sales by Application (2021-2026) & (K Units)
Table 66. Key Market Drivers & Growth Opportunities of Milbexime Anthelmintic
Table 67. Key Market Challenges & Risks of Milbexime Anthelmintic
Table 68. Key Industry Trends of Milbexime Anthelmintic
Table 69. Milbexime Anthelmintic Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Milbexime Anthelmintic Distributors List
Table 72. Milbexime Anthelmintic Customer List
Table 73. Global Milbexime Anthelmintic Sales Forecast by Region (2027-2032) & (K Units)
Table 74. Global Milbexime Anthelmintic Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Americas Milbexime Anthelmintic Sales Forecast by Country (2027-2032) & (K Units)
Table 76. Americas Milbexime Anthelmintic Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. APAC Milbexime Anthelmintic Sales Forecast by Region (2027-2032) & (K Units)
Table 78. APAC Milbexime Anthelmintic Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Europe Milbexime Anthelmintic Sales Forecast by Country (2027-2032) & (K Units)
Table 80. Europe Milbexime Anthelmintic Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. Middle East & Africa Milbexime Anthelmintic Sales Forecast by Country (2027-2032) & (K Units)
Table 82. Middle East & Africa Milbexime Anthelmintic Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Global Milbexime Anthelmintic Sales Forecast by Type (2027-2032) & (K Units)
Table 84. Global Milbexime Anthelmintic Revenue Forecast by Type (2027-2032) & ($ millions)
Table 85. Global Milbexime Anthelmintic Sales Forecast by Application (2027-2032) & (K Units)
Table 86. Global Milbexime Anthelmintic Revenue Forecast by Application (2027-2032) & ($ millions)
Table 87. Elanco Animal Health Basic Information, Milbexime Anthelmintic Manufacturing Base, Sales Area and Its Competitors
Table 88. Elanco Animal Health Milbexime Anthelmintic Product Portfolios and Specifications
Table 89. Elanco Animal Health Milbexime Anthelmintic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Elanco Animal Health Main Business
Table 91. Elanco Animal Health Latest Developments
Table 92. Boehringer Ingelheim Animal Health Basic Information, Milbexime Anthelmintic Manufacturing Base, Sales Area and Its Competitors
Table 93. Boehringer Ingelheim Animal Health Milbexime Anthelmintic Product Portfolios and Specifications
Table 94. Boehringer Ingelheim Animal Health Milbexime Anthelmintic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Boehringer Ingelheim Animal Health Main Business
Table 96. Boehringer Ingelheim Animal Health Latest Developments
Table 97. Merck Animal Health Basic Information, Milbexime Anthelmintic Manufacturing Base, Sales Area and Its Competitors
Table 98. Merck Animal Health Milbexime Anthelmintic Product Portfolios and Specifications
Table 99. Merck Animal Health Milbexime Anthelmintic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Merck Animal Health Main Business
Table 101. Merck Animal Health Latest Developments
Table 102. VIRBAC SA Basic Information, Milbexime Anthelmintic Manufacturing Base, Sales Area and Its Competitors
Table 103. VIRBAC SA Milbexime Anthelmintic Product Portfolios and Specifications
Table 104. VIRBAC SA Milbexime Anthelmintic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. VIRBAC SA Main Business
Table 106. VIRBAC SA Latest Developments
Table 107. Krka Basic Information, Milbexime Anthelmintic Manufacturing Base, Sales Area and Its Competitors
Table 108. Krka Milbexime Anthelmintic Product Portfolios and Specifications
Table 109. Krka Milbexime Anthelmintic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Krka Main Business
Table 111. Krka Latest Developments
Table 112. Zhejiang Hisun Pharmaceutical Co., Ltd Basic Information, Milbexime Anthelmintic Manufacturing Base, Sales Area and Its Competitors
Table 113. Zhejiang Hisun Pharmaceutical Co., Ltd Milbexime Anthelmintic Product Portfolios and Specifications
Table 114. Zhejiang Hisun Pharmaceutical Co., Ltd Milbexime Anthelmintic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Zhejiang Hisun Pharmaceutical Co., Ltd Main Business
Table 116. Zhejiang Hisun Pharmaceutical Co., Ltd Latest Developments
LIST OF FIGURES
Figure 1. Picture of Milbexime Anthelmintic
Figure 2. Milbexime Anthelmintic Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Milbexime Anthelmintic Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Milbexime Anthelmintic Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Milbexime Anthelmintic Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Milbexime Anthelmintic Sales Market Share by Country/Region (2025)
Figure 10. Milbexime Anthelmintic Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Milbexime + Afrana
Figure 12. Product Picture of Milbexime + Praziquantel
Figure 13. Product Picture of Others
Figure 14. Global Milbexime Anthelmintic Sales Market Share by Type in 2026
Figure 15. Global Milbexime Anthelmintic Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Oral Tablets
Figure 17. Product Picture of Oral Granules
Figure 18. Global Milbexime Anthelmintic Sales Market Share by Form in 2026
Figure 19. Global Milbexime Anthelmintic Revenue Market Share by Form (2021-2026)
Figure 20. Product Picture of Regular Preventative Treatment
Figure 21. Product Picture of Therapeutic Treatment
Figure 22. Global Milbexime Anthelmintic Sales Market Share by Function in 2026
Figure 23. Global Milbexime Anthelmintic Revenue Market Share by Function (2021-2026)
Figure 24. Milbexime Anthelmintic Consumed in Cat
Figure 25. Global Milbexime Anthelmintic Market: Cat (2021-2026) & (K Units)
Figure 26. Milbexime Anthelmintic Consumed in Dog
Figure 27. Global Milbexime Anthelmintic Market: Dog (2021-2026) & (K Units)
Figure 28. Milbexime Anthelmintic Consumed in Other
Figure 29. Global Milbexime Anthelmintic Market: Other (2021-2026) & (K Units)
Figure 30. Global Milbexime Anthelmintic Sale Market Share by Application (2025)
Figure 31. Global Milbexime Anthelmintic Revenue Market Share by Application in 2026
Figure 32. Milbexime Anthelmintic Sales by Company in 2026 (K Units)
Figure 33. Global Milbexime Anthelmintic Sales Market Share by Company in 2026
Figure 34. Milbexime Anthelmintic Revenue by Company in 2026 ($ millions)
Figure 35. Global Milbexime Anthelmintic Revenue Market Share by Company in 2026
Figure 36. Global Milbexime Anthelmintic Sales Market Share by Geographic Region (2021-2026)
Figure 37. Global Milbexime Anthelmintic Revenue Market Share by Geographic Region in 2026
Figure 38. Americas Milbexime Anthelmintic Sales 2021-2026 (K Units)
Figure 39. Americas Milbexime Anthelmintic Revenue 2021-2026 ($ millions)
Figure 40. APAC Milbexime Anthelmintic Sales 2021-2026 (K Units)
Figure 41. APAC Milbexime Anthelmintic Revenue 2021-2026 ($ millions)
Figure 42. Europe Milbexime Anthelmintic Sales 2021-2026 (K Units)
Figure 43. Europe Milbexime Anthelmintic Revenue 2021-2026 ($ millions)
Figure 44. Middle East & Africa Milbexime Anthelmintic Sales 2021-2026 (K Units)
Figure 45. Middle East & Africa Milbexime Anthelmintic Revenue 2021-2026 ($ millions)
Figure 46. Americas Milbexime Anthelmintic Sales Market Share by Country in 2026
Figure 47. Americas Milbexime Anthelmintic Revenue Market Share by Country (2021-2026)
Figure 48. Americas Milbexime Anthelmintic Sales Market Share by Type (2021-2026)
Figure 49. Americas Milbexime Anthelmintic Sales Market Share by Application (2021-2026)
Figure 50. United States Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 51. Canada Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 52. Mexico Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 53. Brazil Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 54. APAC Milbexime Anthelmintic Sales Market Share by Region in 2026
Figure 55. APAC Milbexime Anthelmintic Revenue Market Share by Region (2021-2026)
Figure 56. APAC Milbexime Anthelmintic Sales Market Share by Type (2021-2026)
Figure 57. APAC Milbexime Anthelmintic Sales Market Share by Application (2021-2026)
Figure 58. China Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 59. Japan Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 60. South Korea Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 61. Southeast Asia Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 62. India Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 63. Australia Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 64. China Taiwan Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 65. Europe Milbexime Anthelmintic Sales Market Share by Country in 2026
Figure 66. Europe Milbexime Anthelmintic Revenue Market Share by Country (2021-2026)
Figure 67. Europe Milbexime Anthelmintic Sales Market Share by Type (2021-2026)
Figure 68. Europe Milbexime Anthelmintic Sales Market Share by Application (2021-2026)
Figure 69. Germany Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 70. France Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 71. UK Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 72. Italy Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 73. Russia Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 74. Middle East & Africa Milbexime Anthelmintic Sales Market Share by Country (2021-2026)
Figure 75. Middle East & Africa Milbexime Anthelmintic Sales Market Share by Type (2021-2026)
Figure 76. Middle East & Africa Milbexime Anthelmintic Sales Market Share by Application (2021-2026)
Figure 77. Egypt Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 78. South Africa Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 79. Israel Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 80. Turkey Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 81. GCC Countries Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 82. Manufacturing Cost Structure Analysis of Milbexime Anthelmintic in 2026
Figure 83. Manufacturing Process Analysis of Milbexime Anthelmintic
Figure 84. Industry Chain Structure of Milbexime Anthelmintic
Figure 85. Channels of Distribution
Figure 86. Global Milbexime Anthelmintic Sales Market Forecast by Region (2027-2032)
Figure 87. Global Milbexime Anthelmintic Revenue Market Share Forecast by Region (2027-2032)
Figure 88. Global Milbexime Anthelmintic Sales Market Share Forecast by Type (2027-2032)
Figure 89. Global Milbexime Anthelmintic Revenue Market Share Forecast by Type (2027-2032)
Figure 90. Global Milbexime Anthelmintic Sales Market Share Forecast by Application (2027-2032)
Figure 91. Global Milbexime Anthelmintic Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Milbexime Anthelmintic
Figure 2. Milbexime Anthelmintic Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Milbexime Anthelmintic Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Milbexime Anthelmintic Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Milbexime Anthelmintic Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Milbexime Anthelmintic Sales Market Share by Country/Region (2025)
Figure 10. Milbexime Anthelmintic Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Milbexime + Afrana
Figure 12. Product Picture of Milbexime + Praziquantel
Figure 13. Product Picture of Others
Figure 14. Global Milbexime Anthelmintic Sales Market Share by Type in 2026
Figure 15. Global Milbexime Anthelmintic Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Oral Tablets
Figure 17. Product Picture of Oral Granules
Figure 18. Global Milbexime Anthelmintic Sales Market Share by Form in 2026
Figure 19. Global Milbexime Anthelmintic Revenue Market Share by Form (2021-2026)
Figure 20. Product Picture of Regular Preventative Treatment
Figure 21. Product Picture of Therapeutic Treatment
Figure 22. Global Milbexime Anthelmintic Sales Market Share by Function in 2026
Figure 23. Global Milbexime Anthelmintic Revenue Market Share by Function (2021-2026)
Figure 24. Milbexime Anthelmintic Consumed in Cat
Figure 25. Global Milbexime Anthelmintic Market: Cat (2021-2026) & (K Units)
Figure 26. Milbexime Anthelmintic Consumed in Dog
Figure 27. Global Milbexime Anthelmintic Market: Dog (2021-2026) & (K Units)
Figure 28. Milbexime Anthelmintic Consumed in Other
Figure 29. Global Milbexime Anthelmintic Market: Other (2021-2026) & (K Units)
Figure 30. Global Milbexime Anthelmintic Sale Market Share by Application (2025)
Figure 31. Global Milbexime Anthelmintic Revenue Market Share by Application in 2026
Figure 32. Milbexime Anthelmintic Sales by Company in 2026 (K Units)
Figure 33. Global Milbexime Anthelmintic Sales Market Share by Company in 2026
Figure 34. Milbexime Anthelmintic Revenue by Company in 2026 ($ millions)
Figure 35. Global Milbexime Anthelmintic Revenue Market Share by Company in 2026
Figure 36. Global Milbexime Anthelmintic Sales Market Share by Geographic Region (2021-2026)
Figure 37. Global Milbexime Anthelmintic Revenue Market Share by Geographic Region in 2026
Figure 38. Americas Milbexime Anthelmintic Sales 2021-2026 (K Units)
Figure 39. Americas Milbexime Anthelmintic Revenue 2021-2026 ($ millions)
Figure 40. APAC Milbexime Anthelmintic Sales 2021-2026 (K Units)
Figure 41. APAC Milbexime Anthelmintic Revenue 2021-2026 ($ millions)
Figure 42. Europe Milbexime Anthelmintic Sales 2021-2026 (K Units)
Figure 43. Europe Milbexime Anthelmintic Revenue 2021-2026 ($ millions)
Figure 44. Middle East & Africa Milbexime Anthelmintic Sales 2021-2026 (K Units)
Figure 45. Middle East & Africa Milbexime Anthelmintic Revenue 2021-2026 ($ millions)
Figure 46. Americas Milbexime Anthelmintic Sales Market Share by Country in 2026
Figure 47. Americas Milbexime Anthelmintic Revenue Market Share by Country (2021-2026)
Figure 48. Americas Milbexime Anthelmintic Sales Market Share by Type (2021-2026)
Figure 49. Americas Milbexime Anthelmintic Sales Market Share by Application (2021-2026)
Figure 50. United States Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 51. Canada Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 52. Mexico Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 53. Brazil Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 54. APAC Milbexime Anthelmintic Sales Market Share by Region in 2026
Figure 55. APAC Milbexime Anthelmintic Revenue Market Share by Region (2021-2026)
Figure 56. APAC Milbexime Anthelmintic Sales Market Share by Type (2021-2026)
Figure 57. APAC Milbexime Anthelmintic Sales Market Share by Application (2021-2026)
Figure 58. China Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 59. Japan Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 60. South Korea Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 61. Southeast Asia Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 62. India Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 63. Australia Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 64. China Taiwan Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 65. Europe Milbexime Anthelmintic Sales Market Share by Country in 2026
Figure 66. Europe Milbexime Anthelmintic Revenue Market Share by Country (2021-2026)
Figure 67. Europe Milbexime Anthelmintic Sales Market Share by Type (2021-2026)
Figure 68. Europe Milbexime Anthelmintic Sales Market Share by Application (2021-2026)
Figure 69. Germany Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 70. France Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 71. UK Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 72. Italy Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 73. Russia Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 74. Middle East & Africa Milbexime Anthelmintic Sales Market Share by Country (2021-2026)
Figure 75. Middle East & Africa Milbexime Anthelmintic Sales Market Share by Type (2021-2026)
Figure 76. Middle East & Africa Milbexime Anthelmintic Sales Market Share by Application (2021-2026)
Figure 77. Egypt Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 78. South Africa Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 79. Israel Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 80. Turkey Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 81. GCC Countries Milbexime Anthelmintic Revenue Growth 2021-2026 ($ millions)
Figure 82. Manufacturing Cost Structure Analysis of Milbexime Anthelmintic in 2026
Figure 83. Manufacturing Process Analysis of Milbexime Anthelmintic
Figure 84. Industry Chain Structure of Milbexime Anthelmintic
Figure 85. Channels of Distribution
Figure 86. Global Milbexime Anthelmintic Sales Market Forecast by Region (2027-2032)
Figure 87. Global Milbexime Anthelmintic Revenue Market Share Forecast by Region (2027-2032)
Figure 88. Global Milbexime Anthelmintic Sales Market Share Forecast by Type (2027-2032)
Figure 89. Global Milbexime Anthelmintic Revenue Market Share Forecast by Type (2027-2032)
Figure 90. Global Milbexime Anthelmintic Sales Market Share Forecast by Application (2027-2032)
Figure 91. Global Milbexime Anthelmintic Revenue Market Share Forecast by Application (2027-2032)
